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Engineered artificial microenvironments hold enormous potential as models to study 
developmental, physiological, pathological, and regenerative processes under highly defined 
conditions. Such platforms aim at bridging the gap between traditional in vitro 2D culture systems 10 
and animal models. By dissecting the biological complexity into an amenable number of 
parameters, systemic manipulation and study in controllable environments closely resembling the 
in vivo situation is possible. Novel strategies that address the evaluation of either ECM 
components, growth factors or cell–cell interactions on cellular behaviour are being developed. 
However, reliable methods that simulateneously recapitulate the natural instructive 15 
microenvironments in terms of cell and matrix composition, biological cues, hetereogeneity and 
geometry are not yet available. Such spatially-defined microenvironments may be necessary to 
initiate and guide the formation of artificial tissues by morphogenetic processes. In this work, we 
introduce a flexible strategy that relies on the combination of artitificial extracellular matrices with 
patterning techniques as well as a layer-by-layer approach to mimic rationally-designed instructive 20 
milieus. By rationally arrangement of cells and defined biochemical and biophysical extracellular 
cues, we report control of cell migration and generation of an artificial vascularized bone tissue-
like construct.  
Introduction 
Traditionally, tissue engineering has aimed at the creation of 25 
functional three-dimensional (3D) tissues for therapeutic 
applications such as the replacement of damaged tissues. 
While important new mechanical and structural features for 
scaffolds and tissue analogs are continuously being explored, 
our understanding of biological and physical cues, as well as 30 
their spatiotemporal coordination during tissue regeneration is 
limited and consequently restricts the engineering of 
functional tissues based on rational design principles. To gain 
insight into biological processes from in-vitro approaches, the 
recapitulation of cellular microenvironments may therefore be 35 
critical.3-6   
 In vivo, tissues are characterized by complex 3D 
architectures with hierarchical and heterogeneous distribution 
of cells and extracellular matrix (ECM) components. The local 
microenvironment that surrounds cells is mainly composed of 40 
the ECM, neighboring cells, soluble as well as immobilized 
factors, and mechanical forces. The integration of these 
components results in spatiotemporal and tightly controlled 
biochemical and biophysical arrays of signals that will 
determine the dynamic behavior of the cells. Thus, active 45 
microenvironments provide cells with the required information 
fundamental for tissue formation, homeostasis and 
regeneration.7-10 
 The virtual deconstruction of natural ECM components into 
functional subunits has inspired the engineering of artificial 50 
ECM (aECM), whose mechanical properties and biological 
functions can be precisely tailored.11-17 Efforts in this field are 
now focused on the spatial and dynamic arrangement of 
biological function in 3D18-21. In addition, a variety of 2D cell 
patterning techniques, such as bioprinting22-26, electrophoretic 55 
patterning27 and others25, 28-34 have been adapted  in an attempt 
to recapitulate the architecture of living tissues by building  up 
3D structures in a layer-by-layer fashion. Together, these 
platforms are of great value to deconstruct the in vivo 
complexity into single events and to combine them in vitro 60 
into instructive microenvironments and tissue-like models. 
 To initiate and guide the formation of artificial tissues, 
microenvironments consiting of spatially-defined arrangement 
of different cellular entities, growth factors and matrix 
components are likely necessary. Thus, we aimed at 65 
generating guiding microenvironments that can be 
systematically modified and increased in complexity, in a 
controllable manner, in terms of cellular, biochemical and 
biophysical properties as well as in their three-dimensional 
spatial distribution.  70 
Here, we demonstrate that 3D heterogeneous constructs 
with design and organizational complexity can be engineered 
towards specific biological applications by combining three 
different technology platforms: artificial ECM (aECM) 
engineering, robotic printing, and layer-by-layer deposition. 75 
We recapitulate many of the features known to be important in 
natural milieus (ECM, neighbouring cells, soluble factors and 
immobilized ligands, matrix degradability and 3D spatial 
distribution and heterogeneity). By addressing the effect of 
matrix stiffness and susceptibility towards matrix degradation 80 
 on cell spreading, we show that it is possible to rationally 
design an environment to specifically direct and control 
cellular spreading. By systematic evaluation of single 
biological constituents (RGD, VEGF, mono-, co- and tri-
cultures), we demonstrate that the presence of both stromal 5 
cells, besides the adhesion ligand RGD and the pro-angiogenic 
growth factor VEGF, appears to be critical for endothelial 
cells (ECs) to form tube-like structures in artificial 
environments. The relevance of instructive microenvironments 
for the formation of functional tissue-like constructs is 10 
confirmed by the formation of organized bone tissue-like 
constructs that form vessel-like structures in vitro culture. 
Materials and Methods 
PEG and peptides 
PEG-VS and PEG-acrylate were functionalized with Lys and 15 
TG substrates (each substrate containing a cysteine) via 
Michel-type addition to give PEG-TG, PEG-acryl-TG and 
PEG-MMP-Lys, PEG-acryl-MMP-Lys precursors. 
Functionalization and characterization of these precursors was 
performed as described in existing literature.14-15 20 
Formation of PEG-based hydrogels  
Hydrogel networks were formed by factor XIIIa cross-linking 
of 8-arm PEG-TG with 8-arm PEG-MMP-Lys or 8-arm PEG-
acryl-TG with 8-arm PEG-MMP-Lys as previously 
described14-15. Briefly, the covalent cross-linking of 25 
stoichiometrically balanced 8-arm PEG macromers (PEG-Lys 
and PEG-TG; desired PEG %) in tris buffer saline (50 mM, pH 
7.6) was performed by addition of 10 U/ml of thrombin-
activated factor XIIIa in presence of 50 mM calcium chloride. 
The gelation occurred within a few minutes at 37 °C in a 30 
humidified incubator but the cross-linking reaction was 
allowed to proceed for 30 min. 
Activation of FXIII by thrombin 
100 µl of FXIII (200 U/ml, Fibrogammin P1250 CSL Behring) 
were activated in presence of 2.5 mM CaCl2 with 10 µl of 35 
thrombin (20 U/ml, Sigma-Aldrich, CH) for 30 min at 37 °C. 
Small aliquots (200 U/ml) of activated FXIIIa were stored at -
80 °C for further use [14-15]. 
Cell culture 
C2C12 mesenchymal progenitor cells, MC3T3-E1 mouse 40 
preosteoblastic cells, HUVECs and MLO-osteocyte-like cell 
line from mouse were grown in their corresponding standard 
medium. MLO cells were cultured on rat tail type I collagen-
coated tissue culture flasks (Becton Dickinson, FR). The 
cultures were never allowed to become confluent. The cells 45 
were trypsinized and passaged every 2–3 days. All cells were 
grown at 37 °C and 5% CO2 in a humidified atmosphere.  
Screening of medium composition for co-cultures 
A screening of different mediums was performed on 2D and 3D 
monocultures of MC3T3-E1, MLO and HUVEC cells. Cells 50 
were grown in their standard culture medium for at least 12 
hours before their medium was exchanged. Subsequently, 
cellular viability and morphology was assessed 
microscopically. In the case of preosteoblastic MC3T3-E1 
cells, ALP activity without treatment or upon treatment with 55 
rhBMP-2 was quantified for each condition.  
Assay of ALP activity 
Medium was removed, cells were washed twice with PBS and 
samples were incubated for 1 hour in lysis buffer. 
Subsequently, equal volumes of cell lysate and ALP substrate 60 
solution were incubated for 10 min at 37°C. The enzymatic 
reaction was stopped with NaOH (1M) and, after 
centrifugation, the optical absorbance at 410 nm was 
determined. 
Fabrication of PDMS films 65 
Prepared PDMS solution was degassed in a vacuum desiccator, 
introduced into master molds and baked for 2 h at 60 ºC. Once 
cured, PDMS replicas were carefully peeled off.   
Additive layering protocol to form 3D assemblies 
The first layer of hydrogel was cast in a mold consisting of a 70 
glass slide, a PDMS frame shaped spacer and a Sigmacote-
treated glass cover. The glass cover was carefully removed 
after crosslinking and the cells were seeded or spotted. 
Subsequently, PDMS spacers of the same shape were aligned 
and hydrogels were formed by the same sandwich strategy. The 75 
process was consecutively repeated.  
Spotting protocol 
Sequential spotting was performed using standard protein and 
DNA printing protocol adapted to our application. Gel 
precursors were prepared individually and were transferred to a 80 
4 ºC reservoir immediately after addition of FXIIIa to prevent 
evaporation. Between spotting steps, the pin and ring were 
rinsed to prevent cross contamination.  
Assembly of 3D bone tissue-like constructs 
First, a supportive layer of 4% PEG hydrogel containing 200 85 
μM RGD was formed on a glass slide, then MC3T3-E1 cells 
were seeded onto the gel, at a cell density of 2 x 105 cells/cm2, 
and allowed to adhere for 4 hours. Subsequently, 1-µl-sized 
droplets of hydrolytically and proteolytically degradable PEG-
acrylate gels containing single dispersed HUVEC cells (2 x 107 90 
cells/ml) were placed on top of the preosteoblastic monolayer. 
As these gels were designed to rapidly degrade, they were 
formed without RGD to prevent the release of large amounts of 
soluble RGD. Immediately after gelation the whole construct 
was covered with a 1.5% PEG hydrogel containing 50 μM 95 
RGD and 3 x 106 MLO cells / ml. Assemblies were cultured for 
10 days or one month at 37 °C in humidified air mixed with 5% 
CO2 under the standardized culture conditions in presence (or 
absence) of VEGF (100 ng/ml).  
Fixation and staining protocol  100 
All constructs were fixed in 3% PBS-buffered 
paraformaldehyde (PFA), permeabilized with 0.5% Triton X-
100 in PBS and blocked with 1% BSA and 0.5% goat serum. 
Subsequently, samples were incubated with primary antibodies 
against human CD31 or mouse bone specific ALP at 4°C. The 105 
first antibody was detected  by a Cy5-conjugated goat anti-
 mouse IgG (H+L) secondary antibody. F-actin staining was 
performed with either Alexa Fluor 546 phalloidin or Alexa 
Fluor 633 phalloidin and cell nuclei were detected with DAPI. 
Sample evaluation was performed by either confocal laser 
scanning microscopy or epifluorescence microscopy (Leica). 5 
Three-dimensional sampling reconstruction of the confocal z-
stacks was performed with the Imaris software. 
Measurement of tube length 
The artificial tissue constructs were allowed to grow 10 days 
prior to fixation and staining of CD31, actin fibres and nuclei. 10 
After imaging with an epifluorescence microscope, projections 
of CD31 images were thresholded using Image J software and 
the total tubule length was traced and measured using 
AngioQuant Software. The data was normalized to the 
evaluated area and to the control sample (single dispersed 15 
HUVECs, in presence of RGD and VEGF/ area).  
Statistical analysis 
Multiple comparisons were performed with the Dunn’s test, a 
nonparametric rank sum test which generalizes the Bonferroni 
adjustment procedure. 20 
Results and Discussion 
Synthetic PEG-based hydrogels for 2D and 3D cell culture 
We have previously reported a fully defined synthetic PEG-
based hydrogel whose physicochemical characteristics and 
sensitivity to MMP proteolytic degradation can be modulated, 25 
and where growth factors or other biologically active motifs 
can be covalently tethered without compromising their 
biological activity.14-15 The covalent cross-linking of 
stoichiometrically balanced 8-arm PEG macromers which are 
either functionalized with glutamine acceptor peptides (H-30 
NQEQVSPL, referred to as the TG domain)35 or lysine donor 
peptides (Ac-FKGG referred to as the Lys domain)36 is 
catalyzed by FXIIIa transglutaminase. Simultaneous to this 
gelation process, cells can be encapsulated and ligands site-
specifically incorporated37 (Fig. 1a). In such conditions, 35 
human umbilical vein endothelial cells (HUVEC) and 
fibroblasts seeded on 5% (w/v) PEG hydrogels which 
contained 100 μM RGD showed, after 4 hours, comparable 
spreading and cytoskeleton organization as on tissue culture 
plastic substrates (TCP).14-15   40 
 In this work, we evaluate the adhesion and spreading 
conditions for MC3T3-E1 mouse preosteoblastic cells 
(Supplementary Fig. 1) and C2C12 mouse mesenchymal 
progenitor cells (Supplementary Fig. 2). Cells were seeded on 
2D hydrogels containing different concentrations of Lys-RGD 45 
(from 0 μM to 200 μM). The optimal properties of MC3T3-E1 
cells were similar to the ones previously observed for 
fibroblasts and HUVECs (100 μM),14-15 whereas C2C12 cells 
required higher concentrations of RGD (200 μM) to reach 
morphologies comparable to control samples. Furthermore, the 50 
effect of matrix stiffness [from G’ ≈ 250 Pa (2% PEG) to G’ ≈ 
1.500 Pa (5% PEG)] for all RGD concentrations was evaluated 
on C2C12 cells. The number of C2C12 cells attached 
(adhesion) to the hydrogel surface was independent of the 
matrix stiffness and only influenced by the RGD concentration 55 
(Supplementary Fig. 2b). Interestingly, matrix stiffness 
influenced cellular spreading, with maximum spreading 
observed at ca. 250 Pa (2% PEG) (Supplementary Fig. 2c).  
 The influence of the matrix formulation in terms of stiffness 
and susceptibility towards degradation by matrix 60 
metalloproteases (MMPs) on 3D cellular spreading was 
evaluated on MC3T3-E1 cells encapsulated as single dispersed 
cells in FITC-labeled PEG gels that contained 50 μM RGD. As 
observed in confocal images with inverted FITC channels 
(showing matrix defects in green, 2a,c), cells in MMP-65 
sensitive gels of intermediate stiffness (2%), within one day,  
migrate and leave behind tracks where the matrix has been 
remodelled. Nevertheless, in stiff MMP-sensitive gels (2.5%, 
G’ ≈ 450 Pa) cells are only spreading (2e,g). In the MMP-
insensitive intermediate stiffness gels (2%), where proteolytic 70 
migration is not possible, the cross-linking density of the 
matrix permits formation of filopodia but not cell migration in 
a proteolysis independent manner (2b,d). By increasing the 
density of the MMP-insensitive matrix (2.5%) cells are even 
more restricted in their ability to form extensions (2f,h). In 75 
addition, when MC3T3-E1 cells were entrapped in very stiff 
hydrogels (5%; G’ ≈ 1.500 Pa), cells were unable to elongate 
and, after 3 days in culture, stained positive for the membrane-
impermeable ethidium homodimer (Fig. 2j vs 2i). Such results 
are supported by previous findings38. 80 
 Taken together, this data indicates that survival and 
spreading of cells can be efficiently blocked by stiff matrices 
formulated with more than 2.5% PEG, by the absence of a 
MMP-degradable substrate, and by the lack of RGD. 
Therefore, such formulations could, in principle, be employed 85 
to engineer a microenvironment with defined barriers to 
prevent cells from trafficking from one gel area to another and 
to direct cellular spreading. From now on we will refer to 
them as non-permissive substrates.  
Engineering of structured 3D constructs 90 
Hierarchical structures with controlled 3D spatial organization 
of cells, matrix components, and biological cues were 
constructed by combining hydrogel engineering, robotic 
printing technology and layer-by-layer patterning. As 
illustrated in the depiction of the experiment (Fig. 1b), a layer 95 
of hydrogel (2 x 2 x 0.2 mm) was first cast with the help of a 
PDMS mask onto a glass slide and combinations of cells, 
molecules and hydrogels were deposited on the surface as 
either uniform or patterned films. Subsequently, the cycle 
consisting of alignment of a PDMS mold followed by the 100 
deposition of a new hydrogel layer was repeated multiple 
times to form a multi-layered structure. By defining the 
thickness of each PDMS mold (which can be varied from a 
few micrometers to hundreds of micrometers), the patterns of 
the matrix, and the cellular components (independently for 105 
each layer) as well as the number of additive layers, any 
desired construct can be obtained.  
 We first tested the feasibility of the layer-by-layer approach 
by integrating homogeneous layers of cells and gel matrices. 
The reconstructed Confocal image (Fig. 3a) show a z-110 
arrangement of confluent monolayers of C2C12 cells and 
 laminated blocks of approximately 200-μm-thick hydrogels 
containing either labeled molecules (5% PEG, 50 μM Lys-
FITC) or single dispersed cells (2.5% PEG, 50 μM Lys-RGD). 
Since gel layers can be formed in the presence of cells or can 
be used as surfaces for the seeding of cells, such a simple 5 
layering approach allows for a large variety of cell and matrix 
combinations. Next, to increase heterogeneity within each gel 
layer, we explored robotic printing platforms using a contact-
spot arraying technology with a lateral precision of 
approximately 5 μm (Figs. 3b and 3c) and robotic pipetting 10 
with a lateral precision of approximately 100 μm 
(Supplementary Fig. 3). As exemplified with FITC- and 
Alexa-530-labeled peptides, spatially segregated hydrogel 
drops of ca. 100 μm diameter and 20 μm height (Figs. 3b and 
3c) were formed on hydrogel layers of ca. 200 μm by using 15 
spotted array technology [by using robotic pipetting 
workstation (Supplementary Fig. 3); depots of ca. 900 μm 
diameter]. The size of the droplets can be modified by 
adjusting different parameters (eg. pin-head size, amount of 
dispensed liquid, repetitive printing steps). In ddition, due to 20 
the modularity of the PEG hydrogel, the fluorescent-labeled 
ligands are covalently tethered to the substrate thereby 
preventing any cross-contamination between the different 
areas, as observed in the 360º rotating videos of the spotted 
arrays (Supplementary Videos 1 and 2).  25 
Cellular viability and functionality within 3D assemblies 
Once engineering feasibility was proven, we characterized cell 
viability and functionality within 3D assemblies. To test 
whether cells remained viable during the additive layering 
process, we evaluated the capacity of the mouse myoblastic 30 
cell line C2C12 to differentiate into osteoblastic cells upon 
stimulation with soluble recombinant human bone 
morphogenetic protein 2 (rhBMP-2). To confirm the 
differentiation towards an osteoblastic phenotype within the 
construct, the presence of bone specific alkaline phosphatase 35 
(ALP), a marker for osteogenic differentiation, was 
determined immunohistochemically (Fig. 3d). Indeed, the 
uniform red staining indicating ALP expression (cell nuclei in 
blue) after stimulation with rhBMP-2 for 7 days, demonstrated 
that C2C12 cells retained the capacity to respond to a 40 
morphogenic signal.  
 Next, we optimized spotting conditions and evaluated the 
ability of cells to spread after spotting. Spotting is a process 
which, due to low volumes and thus relatively high 
evaporation of water, can induce changes in effective hydrogel 45 
precursor concentrations which may be critical for cell 
survival. In a series of experiments using different 
concentrations of PEG precursor, cell-friendly soft hydrogels 
were found to be formed starting from 1% initial PEG 
precursor content (data not shown). Based on these findings, 50 
MC3T3-E1 cells were spotted as single dispersed cells in 1% 
PEG hydrogels containing 50 μM Lys-RGD. To restrict 
spreading to the site of deposition, the cell-matrix spots were 
embedded in non-permissive hydrogels. Cell spreading within 
the spotted areas (phalloidin in red) clearly indicated that 55 
cellular functions after the spotting procedure remained intact 
(Fig. 3e and Supplementary Fig. 3). 
Directing cellular spreading by heterogeneous patterning 
Based on our matrix engineering and patterning results, we 
rationally designed an instructive microenvironment which has 60 
the ability to direct and control cell migration. MC3T3-E1 
cells were embedded in low density gels and spotted in close 
contact to spatially arranged formulations of hydrogels that 
were either permissive or resistant to cell migration (as 
previously defined). The green regions (Fig. 4) corresponded 65 
to cell-permissive hydrogels which contained 50 μM RGD and 
a cell-friendly PEG concentration (1%), whereas the non-
permissive gels, stained in red, were formulated without RGD 
and with cross-linking densities (3%) that were impenetrable 
to cells. To prevent the escape of cells from the patterned 70 
areas this experimental setup was further embedded within a 
non-permissive hydrogel mass. The ability of PEG-based 
microenvironments to direct cellular behavior by mechanical 
and biological means was assessed by allowing cells to grow, 
proliferate, and spread in the patterned substrates for one 75 
week, under standard culture conditions. CLSM images 
revealed that the cells selectively spread into the migration-
permissive paths and respected the imposed physiochemical 
barriers.  
Artificial structured 3D tissue-like construct 80 
To demonstrate the feasibility of creating 3D structured 
artificial tissue-like models by the assembly of instructive 
microenvironments, we aimed at engineering a well-defined 
and spatially organized bone tissue-like construct containing 
three constitutive bone cells: osteoblasts (MC3T3-E1), 85 
endothelial cells (HUVEC) and osteocytes (MLO) (Fig. 7a). 
One of the main limitations in tissue engineering is to engineer 
functional and vascularized tissues. This issue is particularly 
critical in tissue engineering approaches that involve pre-
seeding of cells on a biomaterial scaffold. Furthermore, the 90 
development and healing of bone tissues in vivo is intimately 
regulated by the formation of a vascular network. Therefore, 
we targeted culture conditions that could support osteogenic 
differentiation of MC3T3-E1, and focused our evaluations on 
the ability of the endothelial cells to form a primitive 95 
vasculature-like structure.  
 We first addressed the medium composition of individual 
2D cell mono-cultures to determine favorable culture 
conditions for later co-culture experiments in 3D. As 
expected, survival and morphology of all cell types was 100 
influenced by the medium composition. Interestingly, MC3T3-
E1 cells (as well as C2C12 cells, data not shown) in HUVEC 
medium exhibited morphological changes and a significantly 
reduced osteogenic differentiation potential, as shown by 
impaired induction of ALP activity in response to rhBMP-2 105 
treatment (Fig. 5a and Supplementary Fig. 4). A combination 
of 4 parts of MC3T3-E1 and 1 part of basal HUVEC medium 
did not affect cell morphology but slightly reduced the 
rhBMP-2 mediated increase of ALP activity (Fig. 5a and 
Supplementary Fig. 4). This data is consistent with the 110 
reported observation that complete endothelial medium is not 
sufficient to support the differentiation of C2C12 cells to 
muscle cells39. We defined the standard culture medium 
conditions based on morphological appearance, best survival 
 and proliferation behavior of all cells as well as differentiation 
potential of MC3T3-E1 cells; 4 parts of MEM-α medium and 1 
part of endothelial cell growth medium w/o supplements 
(BECM). This condition was subsequently tested in 3D 
monocultures.  5 
MC3T3-E1 cells as well as MLO cells embedded in 3D 
PEG matrices (50 µM Lys-RGD) grow well and spread 
normally under such culture conditions (Fig. 5b). HUVEC 
monocultures under the same condition (as well as in standard 
HUVEC medium) adapted an elongated morphology and were 10 
active within the first days of culture. However, they did not 
form aggregates and their viability became compromised in 
the long-term (ca. ≤ 50% viability at day 7) (Fig. 5c). Presence 
of RGD and the addition of 100 ng/mL soluble VEGF to the 
culture medium improved the viability of the cells over time. 15 
However, viability was less than 50% after 10 days in culture 
and cells did not aggregate nor form tube-like structures. 
These observations, in agreement with earlier reports40-42, 
suggest that in a microenvironment consisting of PEG matrix, 
RGD, endothelial medium, and soluble VEGF, single 20 
dispersed HUVECs cannot survive over long periods of time 
and cannot form a capillary network.  
 When co-cultures of single dispersed HUVEC and MLO or 
MC3T3-E1 cells were established in presence of the integrin-
binding ligand (RGD) and VEGF, a significant number of 25 
tube-like aggregates were found in presence of MC3T3-E1 
cells (Fig. 6). Interestingly, a large increase in the number of 
tubular structures was observed in the tri-culture system 
(HUVECs, MC3T3-E1, MLO cells) in the presence of both 
RGD and VEGF (Fig. 6). Stromal cells have been reported in 30 
earlier studies to be critical and sufficient for the induction of 
endothelial tubular structures in biologically derived matrices 
such as collagen, fibrin or matrigel39. Since such materials 
might contain many inherent biological signals, we assume 
that besides the supplementation of appropriate matrix 35 
domains, cell-cell communication might become even more 
critical for the morphogenesis of vascular structures in fully 
defined engineered biomaterials. In support of this, recently 
published data indicates that fully synthetic PEG-based 
matrices, in contrast to the biological counterparts fibrin or 40 
collagen, failed to support the attachment of HUVECs for 
longer than 3 days in culture. When TGFβ-4 was added to the 
same PEG system a vascular-like network formation after 12 
hours was reported on 2D cultures, but not in 3D40.  
 Finally, once the culture conditions were defined, we 45 
assembled the three cell types in a well-controlled synthetic 
microenvironment to create spatially organized vascularized 
bone tissue-like constructs (Fig. 7b). Constructs were formed 
on a supportive layer of 4% PEG hydrogel covered with a 
monolayer of MC3T3-E1. Above this layer, HUVECs were 50 
subsequently positioned in 1µl-sized hydrolytically and 
proteolytically degradable PEG-acrylate gels. These rapidly 
degradable PEG-acrylates were formed in the absence of Lys-
RGD to prevent high concentrations of soluble RGD peptides 
which could potentially interfere with HUVEC viability. 55 
Immediately after gelation, a covering layer of 1.5% PEG 
containing human osteocytes was added. These assemblies 
were allowed to undergo morphogenetic remodeling for 10 
days under the previously optimized medium conditions in the 
presence of 100 ng/ml soluble VEGF. After fixation, cell 60 
nuclei (DAPI/blue), cytoskeleton (phalloidin/green) and 
endothelial specific epitopes CD31 (red) were stained and 
evaluated by CLSM. Three-dimensional reconstructions of the 
z-stacks revealed a dense and interconnected network of CD31 
positive cells where the HUVEC cells were deposited (Fig. 7c-65 
e). At high magnification, CD31 negative cells which were 
likely to be osteoblastic cells were observed surrounding the 
endothelial structures (Fig. 7f). 
 In this section, we have provided evidence for the 
importance of the individual components involved in the 70 
efficient formation of vessel-like structures in artificial 
environments. By varying individual parameters of the system, 
we have defined an instructive in-vitro microenvironment that 
promotes HUVEC re-assembly into tube-like structures in the 
context of bone. In this artificial milieu the presence of the 75 
adhesive ligand RGD, adequate stromal cells and the 
angiogenic growth factor VEGF were necessary to support the 
long term survival of endothelial cells and the induction of 
capillary-like tube formation. Furthermore we have been able 
to engineer a 3D spatially organized vascularized bone tissue-80 
like construct by the assembly of instructive 
microenvironments.  
 The exact role of either preosteoblastic cells or osteocytes 
on endothelial cell function is still unclear. However, recent 
data has indicated that endothelial cells may secrete 85 
prostaglandins and thereby stimulate osteoblasts to provide 
VEGF and produce collagen type I. Indeed gene profiling and 
immunohistochemical evaluations suggested that matrix 
components such as collagen type I might act as a matrix cue 
to give direction to and allow adhesion of a forming vascular 90 
structure43. Osteocytes are also known to play an important 
role in cross-talk with other cells; indeed, they have been 
shown to secrete important signaling molecules such as 
prostaglandin, nitric oxide, glutamate, sclerostin and insulin-
like GF44-46. It is therefore likely that in our culture system, 95 
MLO cells (in response to the tri-culture condition) secret 
signaling molecules that enhance communication between 
OBs and ECs or directly promote the ability of HUVEC cells 
to form tube-like structures. However, at this stage we do not 
know the molecular mechanisms that control the arrangement 100 
of the different cell types. Further evaluation of the influence 
of MC3T3-E1 and MLO cells on the bone tissue-like 
assembly, as well as the determination of the presence of 
lumen and matrix depositions by MC3T3-E1 are the subjects 
of ongoing work. Interestingly, the phenotype of the stromal 105 
cells has been reported to be critical for the induction of 
tubular structures in endothelial cells. For example, 
endothelial cells embedded in matrigel formed tubular 
structures in co-cultures with C2C12 in a sponge–like material 
consisting of 50% poly(L-lactic acid) (PLLA) and 50% 110 
polylactic-glycol acid (PLGA). However, the addition of 
embryonic fibroblast resulted in an increased expression of 
VEGF and in more extended vascular structures.39  
Conclusions 
Based on the widely accepted theory that natural structured 115 
 microenvironments surrounding cells are critical for tissue 
formation, homeostasis and regeneration, we present a 
controllable and reliable platform to generate 3D organized 
instructive microenvironments. We exploit synthetic aECM 
matrices that can be formed in presence of cells under 5 
physiological conditions by an enzyme-mediated reaction. 
Such systems can be engineered towards their mechanical 
properties and biological activity upon a passive background. 
The combination of these aECM with patterning and layering 
approaches allows for the recapitulation of spatially 10 
heterogeneous environments (matrix components, biological 
cues, and cells) that mimic many aspects of the natural 
situation. Such spatially-defined microenvironments may be 
necessary to initiate and guide the formation of artificial 
tissues in vitro. Indeed, the formation of hierarchically ordered 15 
and functional tissues during development and their eventual 
repair in later life is directed by highly orchestrated processes. 
Recapitulating these processes in vitro will largely depend on 
our capacity to understand, control and mimic such signaling 
networks.  20 
 A better understanding of the mechanisms governing 
morphological, physiological and pathophysiological 
processes in vitro, will translate into the development of novel 
clinical therapies that prevent or cure underlying diseases. 
Here, by showing the feasibility of simultaneous patterning of 25 
matrix components, ligands, and cells to direct cellular 
spreading and to form artificial tissue-like constructs, we 
introduce a general method to create organized artificial 
instructive microenvironments. Such a platform allows for the 
disection of biological questions related to tissue remodeling 30 
and morphogenesis, and their independent study in a fully 
controllable artificial environment. Further understanding and 
automation of the procedure could lead to large scale 
production of for example reproducible tissue-like constructs 
suitable for high throughput screening.  35 
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Figure 1 | Scheme of the artificial tissue-like construct formation. 
(a) Scheme of the synthetic artificial extracellular matrix system (aECM). (b) Presentation of 
the fabrication procedure. A first layer of modular designed PEG-based hydrogel is casted 
with the help of a PDMS mask, then combinations of cells, molecules, and hydrogels are 
deposited as either uniform or patterned layers. By repetitive alignment of PDMS molds and 
deposition of new layers, constructs with different heterogeneous design are formed. Layer-
by-layer assembly of individually patterned layers results in a tissue-like construct. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2 | Matrix stiffness and MMPs-susceptibility controlled 3D cell spreading and 
survival.  
(a-b, e-f) Projected confocal z-stacks (10x) of single MC3T3-E1 cells encapsulated in 
intermediate (2%) and stiff (2.5%) FITC-labeled hydrogels. The green channel was inverted 
to visualize cracks present in the matrix (in green and indicated with arrows in Fig. a). (c-d, g-
h) 3D reconstructions of z-stacks at higher magnification (63x). (i,j) Cell survival of MC3T3-
E1 cells encapsulated in 3D PEG gels of different stiffness by live/dead assay. All together, 
these data show the dramatic influence of the matrix properties on the cells which have to 
overcome the physical barrier to be able to migrate within the 3D PEG matrix.  
 
 
 
 
 
 
 
 
 
 Figure 3 | Three dimensional patterning of hydrogels. 
3D constructs were analyzed by confocal microscopy and shown as reconstructed images. (a) 
Homogeneous layers of C2C12 cells and cell-containing or FITC-labeled gels (gel mass either 
in green or unstained). (b and c) Different fluorescently labeled hydrogels arranged by robotic 
printing in defined positions on top of different layers of hydrogel. (d) C2C12 retain their 
differentiation potential as demonstrated by staining of bone specific ALP expression after 
stimulation with BMP-2 for 7 days. (e) MC3T3-E1 cells spotted as single dispersed cells in 
1% PEG spreaded within the droplets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 4 | Instructive PEG-based microenvironment to direct cellular spreading. 
Two formulations of hydrogels were spatially arranged to form regions that either permit 
(green) or act as a barriers (red) for cell spreading. MC3T3-E1 cells were embedded in low 
density hydrogels and deposited in close contact to permissive and non-permissive regions. 
Subsequently the spotted experimental setup was further sandwiched within a non-permissive 
hydrogel mass. At day 0, MC3T3-E1 spots are delimited by circles. After 7 days in culture, 
cells spread within the permissive regions, while avoiding non-permissive hydrogels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5 | 
Establishment of 3D culture conditions for MC3T3-E1, MLO and HUVEC mono-
cultures. 
(a) Correlation between osteogenic differentiation and medium culture conditions. Alkaline 
phosphatase activity of MC3T3-E1 cells in presence or in absence of rhBMP-2 for selected 
medium compositions determined in 2D cultures. (b) Bright field images of 3D MC3T3-E1 
and MLO monocultures in selected medium compositions. (c) Survival of HUVECs in PEG 
gels in presence and absence of RGD and VEGF in two medium compositions. None of the 
tested conditions supported HUVEC survival over long period of time (all conditions; day 10, 
viability ≤50%). Endothelial cell growth medium without supplements (basal endothelial cell 
medium). 
 
  
 
 
 
 
Figure 6 | Contribution of MC3T3-E1 and MLO to HUVEC vessel formation.  
(a) Fluorescence images showing the ability of HUVECs to form tubular-like structures under 
different microenvironmental compositions. (b) The influence of MC3T3-E1 and MLO cells, 
RGD and VEGF on HUVEC vessel formation was quantified by measuring total tubule-
length in a series of combinatorial microenvironments. Only in presence (minimum) of 
MC3T3-E1, VEGF and the integrin-binding ligand (RGD) did HUVECs reassemble to for 
capillary-like networks. Statistical significance analysis; dunn test (n≥3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 7 | Artificial bone tissue-like construct by assembly of an instructive 
microenvironment.  
(a) Schematic cartoon of bone. (b) Illustration of the assembly procedure to form a bone-like 
construct. (c-h) Confocal images of bone tissue-like assemblies allowed to remodel for 10 
days under optimized co-culture condition. (c-e) Monolayer of MC3T3-E1 at the bottom. 
HUVECs assembled into tube-like structures within the PEG droplets in the middle of the 
construct. Aggregates or single dispersed MLOs at the top. High resolution images (63x) of 
(f) the capillary-like network (g) MLO and (h) MC3T3-E1 cells. 3D sampling reconstruction 
was performed by Imaris software.  
 
